Forbion
Venture capital
RollingLast verified 7 Nov 2026
Dutch venture capital firm investing in life sciences and biotech across human health and planetary health, spanning early-stage spin-outs to clinical-stage growth companies.
10 deals in the last 24 months, latest 15 Oct 2026. From its website and its deals in the news.
Key facts
- Stages
- Pre-seed, Seed, Series A, Series B, Series C+
- Sectors
- Biotech & pharma, Cleantech, Agrifood, Materials & chemistry
- Typical round size
- €94M (median of its recent deals, not a ticket)
- Leads rounds
- 70% of recent deals with a known role
- Eligible countries
- Not stated
- Provider based in
- Netherlands
- Timing
- Rolling applications
- Focus
- biotech innovations; human health; planetary health; bioeconomy
- How to apply
- Apply route unknown
- Source
- https://forbion.com/nl
Recent deals
| Company | Round | Sectors | Amount | Role | Announced |
|---|---|---|---|---|---|
| OMass Therapeutics | Series C+ | Biotech & pharma | €275.7M | lead | 15 Oct 2026 |
| Tropic Biosciences UK Limited · United Kingdom | Series C+ | Biotech & pharma, Agrifood | €94M | lead | 19 Mar 2026 |
| Tropic | Series C+ | Biotech & pharma, Agrifood, Climate & energy | €94M | lead | 12 Mar 2026 |
| AAVantgarde Bio | Series B | Biotech & pharma, Healthtech | €126.3M | participant | 3 Nov 2025 |
| CellCentric | Series C+ | Biotech & pharma | €107.5M | lead | 19 May 2025 |
| Azafaros | Series B | Biotech & pharma, Healthtech | €132M | participant | 13 May 2025 |
| EEDEN | Series A | Circular economy, Materials & chemistry, Cleantech | €18M | lead | 29 Apr 2025 |
| Granite Bio | Series B | Biotech & pharma | €62.7M | lead | 24 Apr 2025 |
| Orbis Medicines | Series A | Biotech & pharma | €90M | participant | 6 Jan 2025 |
| Citryll | Series B | Biotech & pharma, Healthtech | €85M | lead | 9 Dec 2024 |
Funds
- Forbion Growth Opportunities Fund IV and Forbion Ventures Fund VIII · €2.3B · closed 6 Oct 2026
Evidence
Short excerpts from the sources, in their original language, that back the facts above.
- Kind
Forbion is a global venture capital firm dedicated to advancing groundbreaking biotech innovations and other sustainable solutions
https://forbion.com/nl - Kind
Forbion is a global venture capital firm dedicated to advancing groundbreaking biotech innovations
http://www.forbion.com/ - Sectors
four sectors, Food, Agriculture, Materials and Environmen
https://forbion.com/nl - Sectors
dedicated to advancing groundbreaking biotech innovations and other sustainable solutions that improve the health of people and our planet.
http://www.forbion.com/
Status history
- 6 Nov 2026: Rolling (first extraction)
Something wrong or out of date? Report an error.
Work at Forbion? Claim this profile to confirm what you invest in.